Menstrual Cycles, Relationship Strain, and High-Reliability Work: What Men Notice, What Women Tend to Conceal, and How to Talk About It

Michael G. Conner, PsyD

Abstract

Men commonly notice predictable windows each cycle when a partner is harder to reach emotionally, communication gets prickly, and extra support is required to keep the home and relationship functional. Those observations measurable for a sizable minority of women, with wide ranges and outliers that averages tend to hide. Across conditions, dysmenorrhea, PMS, PMDD, and endometriosis, days of pain and impaired mood/energy concentrate in the late luteal and perimenstrual phases, with “worst-case” windows stretching to two weeks in some studies, and severe PMDD averaging roughly 6.4 incapacitating days per cycle [1–4]. Workplace evidence shows high presenteeism and under-disclosure; only about one-fifth who miss work explicitly cite menstruation, a pattern that mirrors concealment in intimate relationships [5–7]. In safety-critical settings (aviation, nuclear, petrochemical, surgery) and the military, fitness-for-duty and deploy ability policies assume continuous, unimpaired performance; U.S. DoD retention and non-deployable guidance, NATO pre-/post-deployment health standards, and DOT/FAA/NRC frameworks provide the guardrails [8–16]. This paper validates men’s experience, discusses the strategies many women use to minimize or mask symptoms, and offers practical, respectful questions couples can adopt without pathologizing women or excusing disrespect.

The Menstrual Cycle in Simple Terms: What Happens Biologically, What Changes Physically, and Ways Relationships are Affected

Men often sense that there are “easier weeks” and “harder weeks” in their partner’s month. That pattern tracks a normal, recurring biology.  The menstrual cycle is a monthly conversation between the brain and the ovaries, the hypothalamic-pituitary-ovarian (HPO) axis, involves pulses of brain hormones (GnRH, LH, FSH) to choreograph ovarian hormones (estrogen, progesterone). Those ovarian hormones, in turn, shape the uterine lining and influence the brain’s stress and mood systems. When you understand that signal flow, the shifts you see at home make sense. [2][21][45][46][47]

Biological processes: the four repeating phases

The cycle typically spans about 24–35 days (28 on average), with four overlapping phases. In the menstruation phase, levels of estrogen and progesterone drop. That withdrawal triggers the uterus to shed its lining (bleeding) and sparks a burst of locally made prostaglandins, those chemicals\ squeeze the uterus   causing it to empty. In the follicular phase, rising estrogen helps recruit and mature an egg and often brings a lift in women’s energy, focus, and sociability. At mid-cycle, ovulation occurs as a sharp LH surge releases a mature egg; estrogen is often at its peak. The luteal phase follows; progesterone rises to prepare the body for pregnancy. If no pregnancy occurs, both estrogen and progesterone fall together, and menstruation begins. [1][2][21][45][46][47]

Physiological changes: why symptoms cluster late in the cycle

Two chemical processes explain most of what men notice. First, prostaglandins made inside the uterus increase in the day or two before bleeding and early in menstruation; prostaglandins drive cramping, may cause nausea/loose stools, and contribute to fatigue and sleep disruption, effects that would make anyone more irritable or less patient. Second, late-luteal drops in estrogen and progesterone modulate brain systems that regulate mood and stress (serotonin and GABA-A). Most women adapt; some are unusually sensitive to their hormone shifts and feel large mood swings or anxiety. In PMDD, the severe form, research points to neurosteroid sensitivity (e.g., allopregnanolone acting at GABA-A receptors) and altered serotonin signaling, biology that makes the “prickly window” very uncomfortable for a subset of women. [1][2][4][14][17][18][21][49]

Physical changes men may observe or be aware of

The most noticeable symptoms are pain (cramps), headaches, backache, breast tenderness, bloating, bowel changes, and heavier or lighter bleeding than usual. Pain often lasts 8–72 hours but can start a day or two before bleeding; in some women, especially those later found to have endometriosis, pain is longer and intense. Sleep often gets worse as pain peaks. When pain and poor sleep stack up, attention is shorter, energy is lower, and patience thins, this is the “short fuse” period men describe. [1][3][14][21]

Psychological changes: mood, energy, and cognitive bandwidth

Across the population, many women report late-luteal dips in positive mood, more self-criticism, quicker irritability, and reduced social bandwidth. In mild cases that’s a nuisance, in moderate cases women feel a tangible shift for several days; for those with PMDD, symptoms are severe enough to disrupt work, relationships, and daily life for an average of about six days per cycle. However, some women have longer difficult symptoms, others none. The useful headline for men is pattern recognition: if they’re noticing a few clustered “high-friction” days every month, they’re probably seeing the hormone-linked late-luteal/early-menses window, not imagining. [2][4][17][18][50][51]

Social and work consequences for a woman

Most women are taught to keep menstruation private. At work, many under-report the cause of an absence or simply work through their discomfort, it’s called “presenteeism”, when productivity drops. In a national survey of 32,748 women, 80.7% reported working while symptomatic with measurable productivity loss, 13.8% reported missing work, but only 20.1% told employers the real reason. Concealment happens at home, too: men sense something is off, but when the woman’s bandwidth limits aren’t mentioned, it may lead to mismatched expectations and avoidable conflict. [5]

Marital and partner consequences: predictable windows of friction

Couples research shows lower relationship satisfaction in the late-luteal window, especially if symptoms are moderate to severe. That aligns with men’s reports: more prickly conversations, shorter patience, fewer shared positive moments, and a need for “special handling” to keep the partnership running smoothly. When the pattern is acknowledged, couples can plan around it, shift chores, defer high-stakes discussions, schedule rest, and use agreed-upon signals. When it isn’t acknowledged, partners may misattribute symptoms to character or commitment and get stuck in blame and defensive denial. [10][17][18][33]

Family system consequences: ripple effects on kids, routines, and safety

If a household’s “default settings” assume stable energy and patience every day, late-luteal and perimenstrual dips may destabilize routines: school-morning logistics, bedtime battles, homework support, and co-parent decision-making. Fatigue plus pain can also raise small but real safety risks (e.g., distracted driving on a low-sleep, high-pain morning, cutting corners in high-hazard tasks). Families which treat the menstrual pattern as normal and predictable tend to adapt better: they move some demanding tasks out of the tight window when possible and give both partners permission to say “today’s a low-bandwidth day” without penalty. [5][10][17][18]

Why similar biology is so different among women

Three big reasons explain the variations. First, baseline sensitivity: some women’s brains are more responsive to normal hormone swings (most relevant in PMDD). Second, co-occurring conditions: endometriosis, heavy bleeding, anemia, migraine, and sleep disorders can amplify the distress of a given week. Third, context: stress, shift work, parenting load, and inadequate recovery time can make the same biological process feel much worse. That’s why averages aren’t enough for planning a couple’s shared life; personal data, two or three months of quick daily ratings, beats generic rules of thumb. [4][25][28][29][44][49]

What “plain planning” looks like for couples

A simple playbook can prevent a lot of collateral problems. A couple can track the pattern together for 6–8 weeks (a validated diary like DRSP makes it easy). Forecast the likely 3–7 “high-friction” days each month and protect them where possible: fewer hard conversations, more simple routines, earlier bedtimes, and reassigned chores. Decide on red-flag symptoms (severe pain plus poor sleep; heavy bleeding; panic-like anxiety) that need to trigger a pre-agreed plan, who covers which duties, what gets postponed, which comfort routines help. If the pattern is consistently long or severe, encourage clinical evaluation and talk through medical options, including menstrual-suppression strategies for strenuous trips or safety-critical periods. None of this is intended to blame. its logistics applied to biology. [1][2][4][5][14][44][45][49–51]

Why Men’s Observations Deserve Validation

Men describe cyclical “friction windows”: increased irritability, briefer fuse, lower social bandwidth, more fatigue, and a need for “special handling.” These are not male caricatures; daily-rating and laboratory studies repeatedly show phase-linked increases in anger/irritability, slower conflict-resolution reaction times, and reduced positive affect in late luteal and perimenstrual phases, especially among those with PMS/PMDD [2,17–20]. In other words: the pattern many men notice is consistent with the best available evidence, while the size of the effect varies widely among women. [2,17–20].

Key Definitions (so statistics don’t blur together)

• Primary dysmenorrhea: cramping pelvic pain around menses without pelvic pathology; pain typically begins just before or at onset of bleeding and lasts 8–72 hours [1,21]. Prevalence estimates vary substantially by population and methods, ranging roughly 17–90%, with many modern reviews clustering around 50–70% [1,22–24].

• PMS: physical and affective symptoms recurring in the late luteal phase; pooled global prevalence ≈ 48% but with large cross-national spread (reports from 12% to 98%), a reminder that measurement tools and thresholds matter [3]. Symptom duration usually a few days to two weeks in the premenstrual window [2].

• PMDD: a DSM-5 mood disorder with marked functional impairment; population prevalence commonly 1.8–5.8%. Prospective ratings suggest ~6.4 days of severe symptoms per cycle on average (a “worst-case” tier relative to PMS) [4].

• Endometriosis: chronic inflammatory disease, often with severe cyclical and acyclical pelvic pain; affects ~10% of reproductive-age women globally (range 6–13% in recent health-agency briefs) and is strongly associated with absenteeism/presenteeism and relationship strain [25–29].

How Many Days Are “Low” Each Cycle? Ranges and “Worst-Case” Examples

Averages are blunt instruments here; outer ranges and tail-risk cases are more relevant for relationship planning.

• Pain days (dysmenorrhea): typically, 1–3 days per cycle, but intensity and spillover to fatigue/cognition vary widely [1,21–24]. Worst-case clusters include adolescents/young adults and those later diagnosed with endometriosis [1,24–29].

• Mood/energy/cognition (PMS): most studies find ~5–7 late-luteal days of noticeable symptoms; several reviews and clinical references allow up to ~14 days for moderate-to-severe cases [2,3].

• Severe impairment (PMDD): ~6.4 severe days per cycle (mean) on prospective diaries, roughly 21% of the month, with marked functional disruption at home/work and in relationships [4]. Some individuals report longer spans when anxiety/depressive symptoms trail into menses [4,17,18].

• Work impact (population-level): in a nationwide Dutch survey of 32,748 women, 80.7% reported presenteeism with decreased productivity an average 23.2 days/year; 13.8% reported absenteeism, yet only 20.1% told their employer the absence was due to menstruation [5].

• Work impact (endometriosis “worst-case”): patients averaged ~6.3 work hours lost/week (≈17% of scheduled hours), with 15.8 hours/week lost in the most severe symptom group, substantial and persistent [28].

Takeaway: A nontrivial subset of women experiences 5–14 days per cycle of reduced mood/energy/cognitive bandwidth, and a smaller subset has ~6+ days of severe functional impairment. Men who notice a recurring “harder to connect” window are, in many cases, perceiving a real, phase-locked phenomenon, not inventing it [2–5,17–20].

Concealment and Minimization: Why Men Often Don’t Hear the Full Story

Concealment is common, socially, at work, and in relationships.

• Workplace non-disclosure: Among Dutch respondents who missed school/work due to menstrual symptoms, only 1 in 5 named menstruation as the reason [5].

• Stigma and “private matter” norms: A high-income-countries synthesis concluded menstruation is constructed as embarrassing and requiring concealment, with strong behavioral expectations to keep signs hidden [6,7,30–32].

This same stigma translates at home. Women may minimize, euphemize, or deflect questions about symptoms to avoid being seen as “unreliable” or “dramatic.” That is not manipulation; it is usually a learned response to stigma and social or professional penalties for disclosing “female” limitations [6,7]. Men may face an information gap precisely when planning, logistics, and emotional availability most matter. This is a relationship issue which deserves friendly attention.

Relationship Dynamics: Predictable Windows and Common Friction Points

Daily-rating evidence shows anger/irritability peaks peri-menstrually and reactive aggression is higher in mid-luteal phases among sensitive individuals [17–20]. Laboratory tasks demonstrate slower conflict-resolution reaction times in the luteal phase, even in women without PMS, with greater stress reactivity in those with PMS [20]. Partners, understandably, experience this as edginess, withdrawal, or “walking on eggshells.” Yet many women also report a mid-cycle lift (ovulatory) of positive mood and social energy, which may make late-luteal dips feel even starker by contrast [18,33].

Clinical nuance: Inter-individual variability is high. Many women experience few or no mood shifts; others show large, consistent shifts across multiple domains (anxiety, depression, hostility) [18,33]. That’s the reason couples benefit from tracking one woman’s pattern rather than arguing from averages.

Military and High-Reliability Work Contexts: Continuous Fitness Is an Assumption

Armed services. DoD policy expects members to be deployable and continuously fit for duty; Services must make retention determinations for members non-deployable >12 consecutive months (medical, legal, or administrative categories) [8]. Medical retention standards specify that chronic, refractory conditions that impair duty performance may not meet standards [9]. In practice, menstrual-related impairments are handled under general readiness, medical evaluation, and condition-specific guidance. Pre-/post-deployment health assessment processes are codified within NATO standards (AMedP-4.8) and broader evaluation manuals (AMedP-1.6/STANAG 2560) to maintain force health and capability [10–13].

Cycle management in theater. The Defense Health Agency has adopted Comprehensive Contraceptive Counseling and Access policy (DHA-PI 6200.02), with Service materials noting pharmacies can dispense up to one year of contraception, supporting menstrual suppression for those who choose it [14–16]. Military and obstetrics-gynecology literature explicitly argues for pre-deployment menstrual suppression consultations to reduce unplanned bleeding, pain, and hygiene burdens in austere environments, improving readiness and safety [15,16].

Safety-critical civilian sectors. Many jobs require non-impaired, continuous performance by regulation:

• Aviation (FAA): Medical standards under 14 CFR Part 67 and safety-sensitive functions under FAA/DOT drug- & alcohol-testing rules presume consistent, unimpaired function for pilots, controllers, flight attendants, dispatchers, and mechanics [11,34–36].

• Nuclear power (NRC): 10 CFR Part 26 mandates fitness-for-duty and behavioral observation, with continuous reliability standards for those with unescorted access [12,37].

• Petrochemical & high-hazard processes (OSHA PSM): 29 CFR 1910.119 require rigorous controls to prevent catastrophic releases; teams must function without lapses due to fatigue or impairment [13,38,39].

• Acute care surgery/anesthesia: The Joint Commission’s sentinel-event guidance and perioperative literature underscore human-factors vulnerabilities (fatigue, impaired attention, communication failures) in settings where attention and communication must be continuously reliable [40–43].

Implication: In the military and safety-critical roles, individual variation still matters, but system design assumes uninterrupted fitness and rapidly addresses recurrent impairment regardless of cause. Counseling for menstrual suppression, pain management, and duty-fit evaluation is a readiness tool, not a bias. Oxford Academic

Are Defensive Responses “Manipulative”, or the Product of Stigma and Risk?

Men sometimes encounter evasion, minimization, or hostility when asking about cyclic symptoms. Qualitative syntheses suggest many women experience menstruation as something to hide, both to conform to feminine “competence” norms and to avoid professional or relational penalties [6,7,30–32]. That can be felt as omission or manipulation by partners. The practical reframe: secrecy is often a learned survival strategy, not bad faith. The solution is structured, stigma-aware conversation that normalizes planning around health patterns, just as couples routinely plan around the challenges of shift work, migraines, or diabetes. PLOS

What Men Need to Know Before Long-Term Commitment (with concrete questions)

The goal is predictability and plan-ability, not blame. Use these questions early, ideally when both partners are calm, not inside a tough week.

• Pattern mapping: “Over the last year, how many days per month do you feel your mood, energy, or pain reliably dip? Is it closer to 2–4 days, 5–7, or 10–14?” (Aligns with ranges above.) [1–4]

• Functional impact: “On those days, what drops first, patience, focus, physical stamina, or social energy? What do you want from me in those windows (space, soft tasks, less decision load)?” [2,17–20]

• Disclosure comfort: “How comfortable are you to tell me ‘today is a high-pain or low-bandwidth day’? If not very, what makes it hard? How can I reduce that friction?” (Counters concealment incentives.) [5–7,30–32]

• Treatment stance: “Have you tried options that can shorten or mute your low-days, NSAIDs, tranexamic acid, SSRIs for luteal use, hormonal contraception or suppression, pelvic PT, or endometriosis evaluation? What worked or didn’t?” (Medical decisions are hers; the question gauges orientation to management.) [1–4,25–29]

• High-reliability planning: “If either of us works in a safety-critical role, what’s our plan when your low-days and my shift/mission collide? Would you want a clinician to advise on menstrual suppression or other strategies?” [8–16,34–43]

Communication Playbook (respectful, direct, practical)

State the pattern, not the accusation.
“Over the last six months I’ve noticed that about a week before your period, we both struggle, more snappish moments and shorter patience. I want to plan for this together so neither of us feels ambushed.”

Offer metrics and structure.
“Would you be willing to try a 2-month daily check-in using a validated tool like the DRSP (Daily Record of Severity of Problems) or a brief DSM-5-aligned tracker? We’re not medicalizing you. The goal is to map reality so we can make useful plans.” [4,44]

Negotiate supports and guardrails.
“On ‘red-flag’ days, I’ll take lead on chores and decisions; we’ll defer big topics; we’ll use a code word to pause fights; we’ll have go-to comfort routines; and we’ll revisit what’s working every month.”

Name disclosure as a sign of trust, not weakness.
“When you tell me it’s a low-day, I see that as call for teamwork, not a burden.”

Practical Home Strategies That Work

• Month-over-month mapping: Use a shared calendar with private labels to forecast likely 5–7-day friction windows; revise after 2–3 cycles. [2–4]

• Task/time-shifting: Move high-stakes talks, social events, and complex logistics away from predicted low-days when possible.

• Symptom-first triage: When conflict rises, first ask “pain/fatigue today?” before debating content. If yes, downshift expectations and postpone contentious topics.

• Clinical help if impact is >5–7 days or severe: For longer windows or severe impairment, encourage medical evaluation for dysmenorrhea, PMDD, or endometriosis; evidence-based treatments (e.g., NSAIDs, combined hormonal contraception, luteal-phase SSRIs for PMDD) can materially reduce symptom days and intensity [1–4,25–29].

Opinion (clearly labeled)

My view: Men deserve candid, specific information about a partner’s likely low-days and how that will affect communication, sex, child-care, finances, and safety-critical duties. Women deserve dignity and autonomy in how they manage their symptoms, including the choice not to disclose to employers or relatives. The best couples treat menstrual windows as predictable, manageable risk periods, like hurricane season on a calendar, using measurement-based planning to minimize collateral damage. That is not bias, it’s competent partnership built on information and mutual respect.

Qualified Recommendations

1. Make the invisible visible. Use a 60-day trial of DRSP or a short DSM-5-aligned tracker to quantify days affected, domains affected, and peak days. If severe, escalate for medical evaluation (rule out endometriosis; consider PMDD protocols). [1–4,25–29,44]

2. Plan as a team. Conversations should cover outer-range scenarios: “What if it’s consistently 6–10 days/month?” “What are our child-care and workarounds?” “What if treatment changes libido/mood?” [2–5]

3. If you’re in a high-reliability job (or military): Proactively consult occupational medicine or military clinicians about suppression options and fitness-for-duty expectations. Use official policies (DoDI 6130.03; DoDI 1332.45; DHA-PI 6200.02) and NATO pre-/post-deployment health assessment standards to align your plan with mission reality [8–16].

4. Replace “special handling” with playbooks. Agree on concrete “red day” adjustments: who covers what tasks, what conflicts get deferred, what comfort scripts you’ll use. Re-evaluate monthly.

5. Treat concealment as a design problem. Reduce the social cost of disclosure at home by explicitly linking it to better outcomes for both partners. At work, managers can normalize flexible scheduling and symptom-neutral leave, which reduces presenteeism and the incentive to conceal discomfort [5–7].

Limitations of the Evidence (and why men feel gaslit by averages)

Prevalence and duration estimates vary a lot because studies use different diagnostic thresholds, recall vs. prospective methods, and cultural contexts. Averages compress tails; outer ranges (e.g., PMS up to two weeks; severe PMDD ~6+ days of marked impairment) are vital for planning yet often downplayed in summaries [2–4]. Concealment lowers measured absenteeism and shifts the burden to presenteeism, which is less visible to partners and employers, and harder to quantify [5–7]. The right response is not to distrust science, but to individualize expectations using short-run, prospective tracking in the life you share. PubMed

Conclusion

Men are not imagining this: for a significant minority of women, the menstrual cycle produces predictable windows of lower mood/energy/cognitive bandwidth and discomfort or pain that strain communication and relationship and overall functioning. Concealment is common for understandable reasons. In relationships, candor plus planning beats minimization. In safety-critical work and the military, readiness frameworks assume continuous fitness and offer tools (including menstrual suppression) to manage risk. The most pro-relationship moves a couple can make are to map the pattern, name the needs, and plan their months together.

References

1. Dawood MY. “Primary Dysmenorrhea: Advances in Pathogenesis and Management.” Obstetrics & Gynecology, 2006. https://pubmed.ncbi.nlm.nih.gov/16508273/  

2. StatPearls. “Premenstrual Syndrome.” 2023. https://www.ncbi.nlm.nih.gov/books/NBK560698/

3. Direkvand-Moghadam A., et al. “Epidemiology of Premenstrual Syndrome (PMS), A Systematic Review and Meta-Analysis.” J Clin Diagn Res, 2014. https://pubmed.ncbi.nlm.nih.gov/24701496/

4. StatPearls. “Premenstrual Dysphoric Disorder.” 2023. (Includes ~6.4 severe days/cycle estimate.) https://www.ncbi.nlm.nih.gov/books/NBK532307/

5. Schoep M.E., et al. “Productivity loss due to menstruation-related symptoms: a nationwide cross-sectional survey among 32,748 women.” BMJ Open, 2019. https://bmjopen.bmj.com/content/9/6/e026186 BMJ Open

6. Barrington D.J., et al. “Experiences of menstruation in high-income countries: a systematic review and qualitative evidence synthesis.” PLOS ONE, 2021. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255001 PLOS

7. Barrington D.J., et al. (PMC version). 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8294489/

8. U.S. DoD. “DoDI 1332.45: Retention Determinations for Non-Deployable Service Members.” Change 1, 2021. https://www.esd.whs.mil/Portals/54/Documents/DD/issuances/dodi/133245p.pdf

9. U.S. DoD. “DoDI 6130.03, Vol 2: Medical Standards for Military Service: Retention.” Change 1, 2022. https://www.esd.whs.mil/Portals/54/Documents/DD/issuances/dodi/613003_vol02.PDF

10. NATO. “AMedP-4.8: Pre- and Post-Deployment Health Assessment.” 2024. https://www.coemed.org/files/stanags/03_AMEDP/AMedP-4.8_EDA_V3_2235.pdf

11. NATO. “AMedP-1.6/STANAG 2560: Medical Evaluation Manual (Evaluation of NATO Medical Treatment Facilities).” 2018. https://www.coemed.org/files/stanags/03_AMEDP/AMedP-1.6_EDA_V2_E_2560.pdf

12. NATO. “AJP-4.10: Allied Joint Doctrine for Medical Support.” 2019 (UK edition). https://assets.publishing.service.gov.uk/media/5f71e556d3bf7f47aea92447/doctrine_nato_med_spt_ajp_4_10.pdf

13. NATO (overview of AMedP series). 2019. https://tccc.org.ua/files/downloads/ajp410-allied-joint-doctrine-for-medical-support-en.pdf

14. Navy and Marine Corps Public Health Center. “Deployment Readiness Education for Servicewomen (DRES) Handbook.” March 2025. (Notes DHA-PI 6200.02 allowing up to 12 months of contraception supply.) https://www.med.navy.mil/Portals/62/Documents/NMFA/NMCPHC/root/Health%20Promotion%20and%20Wellness/Women%27s%20Health/Documents/Resources_for_Leadership/DRES%20Handbook_vF_MAR2025.pdf

15. Ricker E.A., et al. “Hormonal contraception and medical readiness for female service members.” AJOG, 2024. https://www.ajog.org/article/S0002-9378%2824%2900630-6/abstract AJOG

16. Wilson D., et al. “Making the Case for Menstrual Suppression for Military Women.” Military Medicine, 2020. https://academic.oup.com/milmed/article/185/7-8/e923/5805226  

17. Handy A.B., et al. “Psychiatric Symptoms Across the Menstrual Cycle in Adult Women.” Curr Psychiatry Rep, 2022 (open-access review). https://pmc.ncbi.nlm.nih.gov/articles/PMC8906247/

18. Kiesner J., et al. “Cyclical Symptom Change Across the Menstrual Cycle.” Clinical Psychological Science, 2016. https://dpss.psy.unipd.it/~massimiliano.pastore/papers/Kiesner_et_al_2016.pdf

19. Peters J.R., et al. “Differential Effects of the Menstrual Cycle on Reactive and Proactive Aggression.” Arch Womens Ment Health, 2020 (PMC). https://pmc.ncbi.nlm.nih.gov/articles/PMC7458153/

20. Hoyer J., et al. “Menstrual Cycle Phase Modulates Emotional–Cognitive Conflict Processing.” PLOS ONE, 2013. https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0059780

21. Itani R., et al. “Primary Dysmenorrhea: Pathophysiology and Management.” Therapeutics and Clinical Risk Management, 2022. https://pubmed.ncbi.nlm.nih.gov/36117490/  

22. Ju H., et al. “Dysmenorrhoea: A Review.” BJOG, 2014. https://pubmed.ncbi.nlm.nih.gov/24373597/  

23. Zaid A.A., et al. “Prevalence of dysmenorrhea: A systematic review and meta-analysis.” Reprod Health, 2022. https://pubmed.ncbi.nlm.nih.gov/36050981/  

24. Habibi N., et al. “Dysmenorrhea and related factors in students.” J Midwifery Reprod Health, 2015. https://pubmed.ncbi.nlm.nih.gov/26234994/  

25. WHO. “Endometriosis, Key Facts.” March 24, 2023. https://www.who.int/news-room/fact-sheets/detail/endometriosis World Health Organization

26. Giudice L.C., et al. “Time for global health policy… Endometriosis.” Lancet, 2023 (Commentary, open access). https://pmc.ncbi.nlm.nih.gov/articles/PMC10696045/

27. Shen D.Y., et al. “Global burden of endometriosis.” Lancet Reg Health – Western Pac, 2025. https://www.sciencedirect.com/science/article/pii/S2590161324000838

28. Soliman A.M., et al. “Effect of Endometriosis Symptoms on Absenteeism and Presenteeism.” J Manag Care Spec Pharm, 2017 (open-access PMC). https://pmc.ncbi.nlm.nih.gov/articles/PMC10398072/

29. Nezhat C.R., et al. “Real-world perspectives on endometriosis disease burden.” Gynecol Minim Invasive Ther, 2025 (PMC). https://pmc.ncbi.nlm.nih.gov/articles/PMC11802455/

30. Åkerman E., et al. “Navigating menstrual stigma and norms.” BMC Public Health, 2024. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-024-20936-5

31. Brantelid I.E., et al. “Menstruation during the lifespan: a qualitative study.” Int J Qual Stud Health Well-being, 2014. https://pubmed.ncbi.nlm.nih.gov/24313552/

32. Hennegan J., et al. “Menstrual experiences and stigma (global).” PLOS Med, 2019. https://journals.plos.org/plosmedicine/article?id=10.1371%2Fjournal.pmed.1002803

33. Hromatko I., et al. “Mid-Cycle Rise in Positive and Drop in Negative Moods.” Brain Sciences, 2023. https://www.mdpi.com/2076-3425/13/1/105

34. FAA. “14 CFR Part 67, Medical Standards and Certification.” 2024 (eCFR). https://www.ecfr.gov/current/title-14/chapter-I/subchapter-D/part-67

35. FAA. “Safety-Sensitive Job Categories for FAA-Mandated Testing.” 2023 (PDF). https://www.faa.gov/media/31166 Federal Aviation Administration

36. U.S. DOT. “Employees performing safety-sensitive functions (Part 40).” Updated 2024/2025. https://www.transportation.gov/odapc/employees_covered_under_DOT_testing_regulation_49_CFR_Part_40

37. NRC. “10 CFR Part 26, Fitness for Duty Programs.” 2025 (eCFR). https://www.ecfr.gov/current/title-10/chapter-I/part-26  

38. OSHA. “Process Safety Management of Highly Hazardous Chemicals (29 CFR 1910.119).” https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.119

39. OSHA. “Process Safety Management, Guidelines (OSHA 3132).” 2000 (PDF). https://www.osha.gov/sites/default/files/publications/osha3132.pdf

40. The Joint Commission. “Sentinel Event Alert: Health care worker fatigue and patient safety.” 2011. https://www.jointcommission.org/en-us/knowledge-library/newsletters/sentinel-event-alert/issue-48/

41. The Joint Commission. “Sentinel Events, Overview.” 2024. https://www.jointcommission.org/en-us/knowledge-library/sentinel-events

42. AORN. “Guidelines in Practice: Team Communication (evidence table).” 2024. https://www.aorn.org/docs/default-source/guidelines-resources/clinical-research/nursing-research/evidence-rating-and-tables/team-communication/team_evidence_table.pdf

43. Singh G., et al. “Root Cause Analysis and Medical Error Prevention.” StatPearls, 2024. https://www.ncbi.nlm.nih.gov/books/NBK570638/

44. Frey B.N., et al. “A DSM-5-based tool to monitor concurrent mood and menstrual symptoms.” BMC Women’s Health, 2022. https://bmcwomenshealth.biomedcentral.com/articles/10.1186/s12905-022-01678-1

Addendum References (new in this section)

45. American College of Obstetricians and Gynecologists (ACOG). “The Menstrual Cycle: Menstruation, Ovulation, and How It All Works.” 2025. https://www.acog.org/womens-health/infographics/the-menstrual-cycle

46. NHS. “Periods and fertility in the menstrual cycle.” 2018. https://www.nhs.uk/conditions/periods/fertility-in-the-menstrual-cycle/

47. Cleveland Clinic. “Menstrual Cycle (Normal Menstruation): Overview & Phases.” 2023. https://my.clevelandclinic.org/health/articles/10132-menstrual-cycle

48. Hantsoo L., Epperson C.N. “Allopregnanolone in Premenstrual Dysphoric Disorder: Evidence for Dysregulated Sensitivity to GABA-A Receptor–Modulating Neuroactive Steroids.” Am J Psychiatry Residents’ Journal (review), 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7231988/

49. Mayo Clinic. “Premenstrual dysphoric disorder: Different from PMS?” 2024. https://www.mayoclinic.org/diseases-conditions/premenstrual-syndrome/expert-answers/pmdd/faq-20058315

50. Cleveland Clinic. “Premenstrual Dysphoric Disorder (PMDD): Causes & Treatment.” 2023. https://my.clevelandclinic.org/health/diseases/9132-premenstrual-dysphoric-disorder-pmdd